Wednesday, October 21, 2026

Novosis Trauma: The Game-Changing Bone Substitute Approved in Malaysia

CG MedTech's Novosis Trauma, a bone substitute for fractures, gains approval in Malaysia, marking its first international registration.

BTS’ V Salutes Fans at IU’s Record-Breaking Concert!

BTS members V and J-Hope attended IU's encore concert in Seoul, capturing moments on social media during the event.

Nvidia and Broadcom See Major Gains After Stock Split

Two of the most influential artificial intelligence...

Dae Hyeon Moon

Author's Latest

How Vieworks Plans to Boost Shareholder Value with 12.4% Dividend Increase in 2026

Vieworks plans to enhance corporate value through growth strategies, increased dividends, and share buybacks to boost shareholder returns.

Discover the Future of Heart Care: Medtronic’s Micra2 Pacemaker Launches with 40% Longer Battery Life

Medtronic launched the Micra 2 leadless pacemaker, enhancing battery life and algorithms for personalized cardiac care.

Pangen Expands Cell-Based Bioassay Services for Customized Drug Development

Pangen is expanding its cell-based activity analysis services after a new contract, enhancing drug evaluation capabilities for various medications.

Lunit’s AI Foundation Model: Transforming Healthcare with 16 Billion Parameters

Medical AI firm Lunit successfully passes the first phase of a national project and enters the second phase of nationwide validation.

Hanmi Pharmaceutical’s Leadership Shake-Up: What Does New CEO Hwang Sang-yeon Mean for the Future?

Hanmi Pharmaceutical Group's management dispute appears to be resolved, marking its first external leadership in 53 years.

Unlocking Genetic Insights: Family Insight Test Launches for High-Risk Families in Asia

3billion launches the Family Insight Test, a genomic diagnostic tool for high-risk families, enhancing genetic risk assessment and family planning.

How Celltrion’s Local Production Strategy Eliminates U.S. Drug Tariffs Influence

Celltrion resolves tariff impacts on U.S. sales, boosting local production and growth opportunities for its biosimilars, including Zymfentra.

SANDRO Dual 2026: The Next Big Thing in Laser Hair Removal Approved by Japan and Taiwan

Wontech's SANDRO Dual 2026 laser device gains certifications in Japan and Taiwan, enhancing its global market presence in cosmetic procedures.

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

FDA’s Game-Changing Guidelines: What Asian Biotech Firms Must Know About Clinical Trial Efficiency

Clinical Trial Design is crucial for success in pharma; FDA's new rules could ease burdens but raise quality standards.

Unlock Radiant Skin: LABSENN’s Calming Serum Offers Powerful Anti-Aging Benefits

HLB Peptide launches LABSENN, a derma-science brand featuring innovative peptide technology and the Peptide Calming Serum for sensitive skin.

2026 Senior Care Market: CareLabs’ Bold New Venture Explained

CareLabs CEO Lee Min-kyung announces plans to enter the senior care market, leveraging digital healthcare for growth and innovation.

Discover the Future of Skincare: Humedix Unveils Re2O ECM at Cosmoprof Bologna 2026

Humedix showcased its Elravie Cosmetic line at Cosmoprof Bologna 2026, featuring the innovative Re2O ECM skin booster for global expansion.

Wantech Targets U.S. Market Expansion at AAD 2026: Key Strategies Revealed

Wontech aims to expand in the U.S. by showcasing products at the AAD and hosting Wave Denver 2026 for healthcare partnerships.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.